Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Inhibitory neurotransmission in the brain is largely mediated by GABA(A) receptors. Potentiation of GABA receptor activation through an allosteric benzodiazepine (BZ) site produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing effects of clinically used BZs such as diazepam. We created genetically modified mice (alpha1 H101R) with a diazepam-insensitive alpha1 subtype and a selective BZ site ligand, L-838,417, to explore GABA(A) receptor subtypes mediating specific physiological effects. These two complimentary approaches revealed that the alpha1 subtype mediated the sedative, but not the anxiolytic effects of benzodiazepines. This finding suggests ways to improve anxiolytics and to develop drugs for other neurological disorders based on their specificity for GABA(A) receptor subtypes in distinct neuronal circuits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, α 1-containing GABAA receptors probably mediate the sedative, amnesic, and anticonvulsant actions of classical benzodiazepines [13, 23].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [23]
Citations
Cites
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Wisden, W., Laurie, D., Monyer, H., & Seeburg, P. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01040.1992 · Cited by 1,543
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
Sieghart, W. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06840-1 · Cited by 1,301
Schwenk, F., Baron, U., & Rajewsky, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5080 · Cited by 1,289
Fritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Barnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Essential functions of synapsins I and II in synaptic vesicle regulation
Rosahl, T. W., Spillane, D., Missler, M., Herz, J., Selig, D. K., Wolff, J. R., Hammer, R. E., Malenka, R. C., & Südhof, T. C. (1995) · Nature · doi:10.1038/375488a0 · Cited by 719
Self-citationType I and Type II GABA A -Benzodiazepine Receptors Produced in Transfected Cells
Pritchett, D. B., Lüddens, H., & Seeburg, P. H. (1989) · Science · doi:10.1126/science.2551039 · Cited by 717
Laurie, D., Seeburg, P., & Wisden, W. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01063.1992 · Cited by 667
Research works printed but not linked: 2
- Barnard, E. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291–313 (1998).
- Sieghart, W. Structure and function of γ-aminobutyric acidA receptor subtypes. Pharmacol. Rev. 47, 181–234 (1995).
Cited by
Items 401–500 of 1,000
Boehm, S. L., Ponomarev, I., Blednov, Y. A., & Harris, R. A. (2006) · Advances in pharmacology · doi:10.1016/s1054-3589(06)54008-6 · Cited by 38
Berdyyeva, T. K., Otte, S. L., Aluisio, L. E., Ziv, Y., Burns, L. D., Dugovic, C., Yun, S., Ghosh, K. K., Schnitzer, M. J., Lovenberg, T. W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112068 · Cited by 38
An Overview of the CNS-Pharmacodynamic Profiles of Nonselective and Selective GABA Agonists
Chen, X., de Haas, S., de Kam, M., & van Gerven, J. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/134523 · Cited by 41
Täuber, M., Calame‐Droz, E., Prut, L., Rudolph, U., & Crestani, F. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02988.x · Cited by 38
GABAA–benzodiazepine receptor complex ligands and stress-induced hyperthermia in singly housed mice
Olivier, B., Bouwknecht, J. A., Pattij, T., Leahy, C. L., van Oorschot, R., & Zethof, T. J. J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00759-6 · Cited by 38
Subtype-selective GABAA receptor mimetics—novel antihyperalgesic agents?
Zeilhofer, H. U., Witschi, R., & Hösl, K. M. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0454-3 · Cited by 37
Chrysin isolated from Pyrus pashia fruit ameliorates convulsions in experimental animals
Sharma, P., Kumari, A., Gulati, A., Krishnamurthy, S., & Hemalatha, S. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1418786 · Cited by 37
Are benzodiazepines really anxiolytic?
Ennaceur, A., Michalíková, S., van Rensburg, R., & Chazot, P. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.10.026 · Cited by 36
Mechanisms underlying synapse‐specific clustering of GABAAreceptors
Thomson, A. M., & Jovanovic, J. N. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07252.x · Cited by 37
Hoepping, A., Diekers, M., Deuther‐Conrad, W., Scheunemann, M., Fischer, S., Hiller, A., Wegner, F., Steinbach, J., & Brust, P. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.10.079 · Cited by 37
Uso de benzodiazepinas en adultos mayores en América Latina
Gómez, S., León, T., Macuer, M., Alves, M., & Ruíz, S. (2017) · Revista médica de Chile · doi:10.4067/s0034-98872017000300009 · Cited by 37
Positive allosteric modulation of native and recombinant GABAA receptors by hops prenylflavonoids
Benkherouf, A. Y., Soini, S. L., Stompor, M., & Uusi‐Oukari, M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.034 · Cited by 37
Witkin, J. M., Cerne, R., Davis, P. G., Freeman, K. B., do Carmo, J. M., Rowlett, J. K., Methuku, K. R., Okun, A., Gleason, S. D., Li, X., et al. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.02.013 · Cited by 37
Savić, M. M., Obradovic, D. I., Ugrešić, N. D., COOK, J., YIN, W., & Bokonjić, D. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.09.011 · Cited by 39
Subtype-selective GABAergic drugs facilitate extinction of mouse operant behaviour
McCabe, C., Shaw, D., Atack, J. R., Street, L. J., Wafford, K. A., Dawson, G. R., Reynolds, D. S., & Leslie, J. C. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.004 · Cited by 37
Self-citationRowlett, J. K., Tornatzky, W., Cook, J. M., Ma, C., & Miczek, K. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29534-3 · Cited by 37
Atack, J. R., Wong, D. F., Fryer, T. D., Ryan, C., Sanabria, S., Zhou, Y., Dannals, R. F., Eng, W.-S., Gibson, R. E., Burns, H. D., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157909 · Cited by 36
Self-citationFollesa, P., Mostallino, M. C., Biggio, F., Gorini, G., Caria, S., Busonero, F., Murru, L., Mura, M. L., Sanna, E., & Biggio, G. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03303.x · Cited by 36
McEown, K., & Treit, D. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.012 · Cited by 37
June, H. L., Foster, K. L., Eiler, W. J. A., Goergen, J. J., Cook, J. B., Johnson, N., Mensah‐Zoe, B., Simmons, J. O., June, H. L., Yin, W., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301097 · Cited by 36
Guerrini, G., Costanzo, A., Ciciani, G., Bruni, F., Selleri, S., Costagli, C., Besnard, F., Costa, B., Martini, C., Siena, G. D., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.08.058 · Cited by 36
Effects of prenatal malnutrition on GABAA receptor α1, α3 and β2 mRNA levels
Steiger, J. L., Alexander, M. J., Galler, J. R., Farb, D. H., & Russek, S. J. (2003) · Neuroreport · doi:10.1097/00001756-200309150-00015 · Cited by 36
Zeng, X., Hu, K., Chen, L., Zhou, L., Luo, W., Li, C., Zong, W., Chen, S., Gao, Q., Zeng, G., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01020 · Cited by 35
Zolpidem dependence and withdrawal seizure--report of two cases.
Wang, L., Ree, S., Chu, C.-L., & Juang, Y. (2011) · PubMed · Cited by 35
Licata, S. C., Platt, D. M., Cook, J. M., Linn, M. L. V., & Rowlett, J. K. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1401-7 · Cited by 35
Reynolds, D. S., O'Meara, G. F., Newman, R. J., Bromidge, F. A., Atack, J. R., Whiting, P. J., Rosahl, T. W., & Dawson, G. R. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00370-2 · Cited by 35
Self-citationEffects of drugs that potentiate GABA on extinction of positively-reinforced operant behaviour
Leslie, J. C., Shaw, D., McCabe, C., Reynolds, D. S., & Dawson, G. R. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.01.003 · Cited by 35
Self-citationIn vivo genetics of anaesthetic action
Nash, H. A. (2002) · British Journal of Anaesthesia · doi:10.1093/bja/aef159 · Cited by 35
The Neurobiology of Anxiety: Potential for Co-Morbidity of Anxiety and Substance Use Disorders
McNaughton, N. (2007) · Springer eBooks · doi:10.1007/978-0-387-74290-8_2 · Cited by 34
Carotti, A., Altomare, C., Savini, L., Chiasserini, L., Pellerano, C., Mascia, M. P., Maciocco, E., Busonero, F., Mameli, M., Biggio, G., et al. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00527-3 · Cited by 34
Fragile X syndrome: from gene discovery to therapy
Heulens, I. (2011) · Frontiers in Bioscience · doi:10.2741/3785 · Cited by 31
Auta, J., Impagnatiello, F., Kadriu, B., Guidotti, A., & Costa, E. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.002 · Cited by 34
Inhibitory Ligand-Gated Ion Channels as Substrates for General Anesthetic Actions
Zeller, A., Jurd, R., Lambert, S., Arras, M., Drexler, B., Grashoff, C., Antkowiak, B., & Rudolph, U. (2008) · Springer eBooks · doi:10.1007/978-3-540-74806-9_2 · Cited by 34
Nickolls, S. A., Mace, H., Fish, R. L., Edye, M. E., Gurrell, R., Ivarsson, M., Pitcher, T., Tanimoto-Mori, S., Richardson, D. S., Sweatman, C., et al. (2011) · Advances in Pharmacological Sciences · doi:10.1155/2011/608912 · Cited by 34
Clobazam for treatment of epilepsy
Giarratano, M., Standley, K., & Benbadis, S. R. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.647686 · Cited by 34
The clinical impact of epilepsy genetics
Johnson, M. R., & Sander, J. W. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.4.428 · Cited by 34
Pharmacodynamic response profiles of anxiolytic and sedative drugs
Chen, X., Broeyer, F. J. F., de Kam, M., Baas, J., Cohen, A. F., & van Gerven, J. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13204 · Cited by 33
Mitchell, S. J., Maguire, E. P., Cunningham, L., Gunn, B. G., Linke, M., Zechner, U., Dixon, C. I., King, S. L., Stephens, D., Swinny, J. D., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.08.021 · Cited by 33
Hiyoshi, T., Kambe, D., Karasawa, J., & Chaki, S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.08.047 · Cited by 33
Vlainić, J., & Peričić, D. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.03.010 · Cited by 33
Ralvenius, W. T., Acuña, M. A., Benke, D., Matthey, A., Daali, Y., Rudolph, U., Desmeules, J. A., Zeilhofer, H. U., & Besson, M. J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.004 · Cited by 34
Insights into the Structure and Pharmacology of GABAAReceptors
Carter, C. R. J., Kozuska, J. L., & Dunn, S. M. J. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.178 · Cited by 35
Bentzen, B. H., & Grunnet, M. (2011) · Advances in Pharmacological Sciences · doi:10.1155/2011/578273 · Cited by 33
de Lucas, A. G., Ahring, P. K., Larsen, J. S., Rivera-Arconada, I., Lopez-Garcia, J. A., Mirza, N. R., & Munro, G. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.12.010 · Cited by 32
Zuiker, R. G. J. A., Chen, X., Østerberg, O., Mirza, N. R., Muglia, P., de Kam, M., Klaassen, E. S., & van Gerven, J. M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115620435 · Cited by 32
Behavioral Functions of GABAA Receptor Subtypes - The Zurich Experience
Crestani, F., & Rudolph, U. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.10.001 · Cited by 32
Blednov, Y. A., Benavidez, J. M., Black, M., Chandra, D., Homanics, G. E., Rudolph, U., & Harris, R. A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.016 · Cited by 32
Lu, C. Y., Liu, D. X., Jiang, H., Pan, F., Ho, C. S. H., & Ho, R. (2017) · Neural Plasticity · doi:10.1155/2017/5715816 · Cited by 32
Balk, M., Hentschke, H., Rudolph, U., Antkowiak, B., & Drexler, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-03154-5 · Cited by 32
Mikkelsen, J. D., Bundzikova, J., Larsen, M. H., Hansen, H. H., & Kiss, A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.044 · Cited by 32
Mathiasen, L., & Mirza, N. R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0119-z · Cited by 32
García‐Gutiérrez, M. S., & Manzanares, J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109106910 · Cited by 32
Plappert, C. F., & Pilz, P. K. D. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00299-6 · Cited by 31
Alpha2-containing GABAA receptors are involved in mediating stimulant effects of cocaine
Morris, H. V., Dawson, G. R., Reynolds, D. S., Atack, J. R., Rosahl, T. W., & Stephens, D. N. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.02.010 · Cited by 29
Self-citationGross, A., Sims, R. E., Swinny, J. D., Sieghart, W., Bolam, J. P., & Stanford, I. M. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07552.x · Cited by 31
Chen, X., Jacobs, G. E., de Kam, M. L., Jaeger, J., Lappalainen, J., Maruff, P. T., Smith, M. A., Cross, A. J., Cohen, A. F., & van Gerven, J. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000251 · Cited by 31
Fischer, B. D., Schlitt, R. J., Hamade, B. Z., Rehman, S., Ernst, M. C., Poe, M. M., Li, G., Kodali, R., Arnold, L. A., & Cook, J. M. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.03.001 · Cited by 31
Gurrell, R., Dua, P., Feng, G., Sudworth, M., Whitlock, M., Reynolds, D. S., & Butt, R. P. (2018) · Pain · doi:10.1097/j.pain.0000000000001267 · Cited by 31
Self-citationYang, J., Shen, C.-J., Chen, X.-J., Kong, Y., Liu, Y.-S., Li, X., Chen, Z., Gao, T., & Li, X. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy316 · Cited by 31
Schweigert, I. D., de Oliveira, D. L., Scheibel, F., da Costa, F., Wofchuk, S. T., Souza, D. O., & Perry, M. L. S. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2004.10.013 · Cited by 32
Effect of clobazam as add-on antiepileptic drug in patients with epilepsy.
Joshi, R., Tripathi, M., Gupta, P., & Gupta, Y. K. (2014) · PubMed Central · Cited by 31
Baker, P. M., Pennefather, P., Orser, B. A., & Skinner, F. K. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00052.2002 · Cited by 31
Wang, F., Xu, Z., Yuen, C. T., Chow, C. Y., Lui, Y. L., Tsang, S. Y., & Xue, H. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.018 · Cited by 31
van Bogaert, M. J. V., Oosting, R. S., Tóth, M., Groenink, L., van Oorschot, R., & Olivier, B. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.058 · Cited by 30
Wikinski, S., Acosta, G. B., Gravielle, M. C., Bonavita, C. D., Bisagno, V., de Plazas, S. F., & Rubio‐Terres, C. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00480-4 · Cited by 31
Hippocampal α5-GABAA Receptors Modulate Dopamine Neuron Activity in the Rat Ventral Tegmental Area
Perez, S. M., McCoy, A. M., Prévot, T. D., Mian, M. Y., Carreno, F. R., Frazer, A., Cook, J. M., Sibille, E. L., & Lodge, D. J. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.12.010 · Cited by 30
Bernardo, A. M., Lee, P., Marcotte, M. D., Mian, M. Y., Rezvanian, S., Sharmin, D., Kovačević, A., Savić, M. M., Cook, J. M., Sibille, E. L., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01360-y · Cited by 30
A novel GABAA alpha 5 receptor inhibitor with therapeutic potential
Ling, I., Mihalik, B., Etherington, L.-A., Kapus, G. L., Pálvölgyi, A., Gigler, G., Kertész, S., Gaál, A., Pallagi, K., Kiricsi, P., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.005 · Cited by 30
Harris, D. L., Clayton, T., Cook, J. M., Sahbaie, P., Halliwell, R. F., Furtmüller, R., Huck, S., Sieghart, W., & DeLorey, T. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701433b · Cited by 30
Atack, J. R., Alder, L., COOK, S., SMITH, A., & McKernan, R. M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.004 · Cited by 30
Self-citationMirza, N. R., Rodgers, R. J., & Mathiasen, L. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094003 · Cited by 30
An anxiety-like phenotype in mice selectively bred for aggression
Nehrenberg, D. L., Rodriguiz, R. M., Cyr, M., Zhang, X., Lauder, J. M., Gariépy, J., & Wetsel, W. C. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.02.010 · Cited by 30
Hammer, H., Ebert, B., Jensen, H. S., & Jensen, A. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120239 · Cited by 29
Biggio, F., Gorini, G., Caria, S., Murru, L., Mostallino, M. C., Sanna, E., & Follesa, P. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.002 · Cited by 30
Witkin, J. M., Li, G., Golani, L. K., Xiong, W., Smith, J. L., Ping, X., Rashid, F., Jahan, R., Cerne, R., Cook, J. M., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.260968 · Cited by 29
Femenía, T., Pérez-Rial, S., Urigüen, L., & Manzanares, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110367724 · Cited by 29
Production of conditional point mutant knockin mice
Skvorak, K. J., Vissel, B., & Homanics, G. E. (2006) · genesis · doi:10.1002/dvg.20222 · Cited by 29
Influence of GABAAReceptor γ2Splice Variants on Receptor Kinetics and Isoflurane Modulation
Benkwitz, C., Banks, M. I., & Pearce, R. A. (2004) · Anesthesiology · doi:10.1097/00000542-200410000-00018 · Cited by 28
Wang, C., Li, M., Sawmiller, D. R., Fan, Y., Ma, Y., Tan, J., Ren, Y., & Li, S. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.028 · Cited by 28
GABAAreceptors as targets for novel anxiolytic drugs
Rupprecht, R., Eser, D., Zwanzger, P., & Möller, H. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970600868525 · Cited by 29
The French addictovigilance network clinical assessment: Z-drugs, true false twins
Rousselet, M., Feuillet, F., Gérardin, M., Jolliet, P., Hardouin, J.-B., & Victorri‐Vigneau, C. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1346084 · Cited by 28
Duke, A. N., Meng, Z., Platt, D. M., Atack, J. R., Dawson, G. R., Reynolds, D. S., Tiruveedhula, V. V. N. P. B., Li, G., Stephen, M. R., Sieghart, W., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.249250 · Cited by 28
Self-citationFiorelli, R., Rudolph, U., Straub, C. J., Feldon, J., & Yee, B. K. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830dc0c7 · Cited by 26
Studying cerebellar circuits by remote control of selected neuronal types with GABA-A receptors
Wisden, W., Murray, A., McClure, C., & Wulff, P. (2009) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.029.2009 · Cited by 28
Sleep-Aids Derived from Natural Products
Hu, Z., Oh, S., Ha, T.-W., Hong, J. T., & Oh, K. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2018.099 · Cited by 28
Simen, A. A., Whitlock, M., Qiu, R., Miceli, J. J., Zumpano, L., Metz, M. D., Dua, P., & Binneman, B. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000997 · Cited by 28
Groves, J. O., Guscott, M. R., Hallett, D. J., Rosahl, T. W., Pike, A. J., Davies, A. L. M., Wafford, K. A., & Reynolds, D. S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04890.x · Cited by 28
Self-citationCao, Y., Yan, H. F., Yu, G., & Su, R. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117033 · Cited by 27
Newman, E. L., Smith, K. S., Takahashi, A., Chu, A., Hwa, L. S., Chen, Y., DeBold, J. F., Rudolph, U., & Miczek, K. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4069-9 · Cited by 27
Savić, M. M., Obradovic, D. I., Ugrešić, N. D., Cook, J. M., Sarma, P., & Bokonjić, D. R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2170-1 · Cited by 27
Fischer, B. D., Atack, J. R., Platt, D. M., Reynolds, D. S., Dawson, G. R., & Rowlett, J. K. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2142-y · Cited by 26
Self-citationHerde, A. M., Benke, D., Ralvenius, W. T., Mu, L., Schibli, R., Zeilhofer, H. U., & Krämer, S. D. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.02.022 · Cited by 27
Exploiting the Indole Scaffold to Design Compounds Binding to Different Pharmacological Targets
Taliani, S., Settimo, F. D., Martini, C., Laneri, S., Novellino, E., & Greco, G. (2020) · Molecules · doi:10.3390/molecules25102331 · Cited by 27
Guerrini, G., Ciciani, G., Costanzo, A., Daniele, S., Martini, C., Ghelardini, C., Mannelli, L. D. C., & Ciattini, S. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.02.027 · Cited by 27
Molecular Actions of (S)-Desmethylzopiclone (SEP-174559), an Anxiolytic Metabolite of Zopiclone
Fleck, M. W. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033886 · Cited by 27
Akulov, A. A., Вараксин, М. В., Чарушин, В. Н., & Чупахин, О. Н. (2019) · ACS Omega · doi:10.1021/acsomega.8b02916 · Cited by 27
Mouse Molecular Genetic Technologies: Promise for Psychiatric Research
Tecott, L. H. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.11.995 · Cited by 25
Anderson, A., Belelli, D., Bennett, D. J., Buchanan, K. I., Casula, A. M., Cooke, A., Feilden, H., Gemmell, D. K., Hamilton, N. M., Hutchinson, E. J., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010903i · Cited by 27
Goodacre, S. C., Hallett, D. J., Carling, R. W., Castro, J. L., Reynolds, D. S., Pike, A. J., Wafford, K. A., Newman, R. J., Atack, J. R., & Street, L. J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.12.027 · Cited by 27
Self-citationInvolvement of the GABAA receptor α subunit in the mode of action of etifoxine
Mattei, C., Taly, A., Soualah, Z., Saulais, O., Henrion, D., Guérineau, N. C., Verleye, M., & Legros, C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.034 · Cited by 26
Metadata
- Authors
- McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., Garrett, L., Bristow, L., Marshall, G., Macaulay, A., Brown, N., Howell, O., Moore, K. W., Carling, R. W., Street, L. J., Castro, J. L., Ragan, C. I., Dawson, G. R., & Whiting, P. J.
- Affiliations
- MSD (UK) Limited (United Kingdom) (GB)
- Corresponding author
- McKernan, R. M.
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2000-06
- Volume
- 3
- Issue
- 6
- Pages
- 587-592
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2001619275
- Cited by
- 944
- References
- 35
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 18 · 2023: 23 · 2022: 14 · 2021: 23 · 2020: 30 · 2019: 24 · 2018: 37 · 2017: 22 · 2016: 30 · 2015: 29 · 2014: 32 · 2013: 36 · 2012: 37
- FWCI
- 19.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, sedation, anxiolytic effects, genetically modified mice, inhibitory neurotransmission, diazepam
- MeSH terms
- Allosteric Site, Animals, Anticonvulsants, Azides, Benzodiazepines, Binding, Competitive, Brain, Cell Line, Diazepam, Dose-Response Relationship, Drug, Flumazenil, Fluorobenzenes, Hypnotics and Sedatives, Ligands, Mice, Inbred C57BL, Mice, Mutant Strains, Motor Activity, Receptors, GABA-A, Reflex, Startle, Anti-Anxiety Agents, Triazoles, Patch-Clamp Techniques, Mice, GABA-A Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.